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Redox regulation of Nox
Reactive oxygen species (ROS)
A B S T R A C T
NADPH oxidase Nox4 is expressed in a wide range of tissues and plays a role in cellular signaling by
providing reactive oxygen species (ROS) as intracellular messengers. Nox4 oxidase activity is thought to
be constitutive and regulated at the transcriptional level; however, we challenge this point of view and
suggest that speciﬁc quinone derivatives could modulate this activity. In fact, we demonstrated a
signiﬁcant stimulation of Nox4 activity by 4 quinone derivatives (AA-861, tBuBHQ, tBuBQ, and
duroquinone) observed in 3 different cellular models, HEK293E, T-RExTM, and chondrocyte cell lines. Our
results indicate that the effect is speciﬁc toward Nox4 versus Nox2. Furthermore, we showed that
NAD(P)H:quinone oxidoreductase (NQO1) may participate in this stimulation. Interestingly, Nox4
activity is also stimulated by reducing agents that possibly act by reducing the disulﬁde bridge (Cys226,
Cys270) located in the extracellular E-loop of Nox4. Such model of Nox4 activity regulation could provide
new insight into the understanding of the molecular mechanism of the electron transfer through the
enzyme, i.e., its potential redox regulation, and could also deﬁne new therapeutic targets in diseases in
which quinones and Nox4 are implicated.
 2013 Elsevier Inc. All rights reserved.
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Quinone derivative compounds induce a broad spectrum of
effects in humans and represent a class of toxicological inter-
mediates, which may induce acute cytotoxicity, immunotoxicity,Abbreviations: AA-861, 2-(12-hydroxydodeca-5,10-diynyl)-3,5,6-trimethyl-p-ben-
zoquinone; BQ, benzoquinone; CGD, chronic granulomatous disease; CHX,
cycloheximide; DPI, diphenyliodonium; Duroquinone, 2,3,5,6-tetramethyl-1,4-
benzoquinone; HQ, hydroquinone; tMetBQ, 2,5-dimethyl-1,4-benzoquinone;
LDH, lactate dehydrogenase; 5-LO, 5-lipoxygenase; NQO1, NAD(P)H:quinone
oxidoreductase 1; PMA, phorbol 12-myristate 13-acetate; PMN, polymorphonu-
clear cells; RLU, relative light unit; ROS, reactive oxygen species; tBuBHQ, 2,5-di-
tert-butyl-1,4-benzo-hydroquinone; and tBuBQ, 2,5-di-tert-butyl-1,4-benzoqui-
none.
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http://dx.doi.org/10.1016/j.bcp.2013.03.023and carcinogenesis, and lead to cellular damage [1]. They can be
formed from benzene or polycyclic aromatic hydrocarbons and are
toxicologically important components of air pollution [2] and
cigarette smoke [3]. Among the enzymes that modulate quinone
toxicity, the NAD(P)H quinone oxidoreductase type 1 (NQO1; EC
1.6.99.2) is one of the most important enzymes. NQO1 is a
homodimeric ﬂavoenzyme that catalyses the obligatory two-
electron reduction of quinones to hydroquinones [4]. NQO1
activity can protect animal cells from the deleterious and
carcinogenic effects of quinones by preventing the one-electron
reduction of quinones by other reductases; however, prolonged
exposure to environmental contamination, which contains qui-
nones, damages pulmonary tissue and leads to airway inﬂamma-
tion and pathologies through an oxidative stress mechanism [5,6].
NQO1 is mainly cytosolic but it has been described to be expressed
at plasma membrane [7]. Semiquinone radicals of inhaled airborne
particulate matter are believed to cause oxidative stress by
generating reactive oxygen species (ROS), as reported in the lung
[8]. Furthermore, diesel exhaust particles composed of polycyclic
M.V.C. Nguyen et al. / Biochemical Pharmacology 85 (2013) 1644–1654 1645aromatic hydrocarbons and quinones are involved in a cellular ROS
production associated with lung function impairment via a Nox4
redox-dependent mechanism [9].
Nox4 belongs to the NADPH oxidase family that contains 7
members [10–12]. The function of those enzymes is exclusively
dedicated to the production of ROS, which are essential signaling
molecules. Primary discovered in kidney tissue [13], Nox4 appears
to be ubiquitously distributed. Its dysfunction has been linked to
several pathologies including hypertension [14], diabetes [15],
atherosclerosis [16], cancer [17], osteoarthritis [18] and inﬂam-
mation [19], and Nox4 represent a potential therapeutic target
[20]. Despite its wide distribution, its activation mechanisms at
the molecular level are unclear. It is of therapeutic interest to
elucidate the mechanism of Nox4 NADPH oxidase activity. While
activity of Nox1, Nox2, and Nox3 largely depends on the presence
of cytosolic activator or organizer subunits, no well-known
NADPH oxidase partners, beside p22phox, have been identiﬁed or
shown to activate Nox4 [21–23]. However, two partners of Nox4
have been described recently: the protein disulﬁde isomerase
(PDI) and the polymerase DNA directed-delta-interacting protein
(Poldip2). Nox4 is unique among other Nox isoenzymes in that its
activity is constitutive and may depend on a speciﬁc conformation
of the dehydrogenase DH domain that should allow a spontaneous
transfer of electrons from NADPH to FAD and to the hemes [24,25].
Data from various studies indicated clearly that Nox4 activity is
regulated at the mRNA level, implying that an increase or decrease
of ROS production by Nox4 is correlated to an up regulation
[9,16,26–33] or to a decline [34] of Nox4 transcripts. Although it
has not been reported yet, post-translational regulation of Nox4
oxidase activity cannot be excluded.
In this study, we provide the ﬁrst evidence that Nox4 activity
can be modulated independently of both transcriptional and
translational processes. We showed a dual effect of quinone
compounds, as being activators or inhibitors of Nox4 ROS
production depending on their redox potential (E). We suggest
that quinones derivatives could modulate Nox4 activity by a redox
regulation pathway. Moreover, NQO1 is introduced as an
intermediate between quinones and Nox4 activation, suggesting
a functional interaction between Nox4 and NQO1. The results
argue in favor of a modulation of Nox4 activity by a new family of
chemical compounds and suggest a potential role of Nox4 in
pathologies implying quinone toxicity.
2. Materials and methods
2.1. Materials
Polyclonal antibody against 5-lipoxygenase (5-LO) (Cayman, Ann
Arbor, USA) was a generous gift from F. Stanke (Grenoble, France).
pEF6V5/HisB vector, penicillin, streptomycin, L-glutamine, Dulbec-
co’s modiﬁed Eagle’s medium (DMEM), fetal bovine serum (FBS),
trypsin, Earles’s balanced salts (EBSS), geneticin, Fluo-3/AM, BAPTA/
AM, and TRIzol1 were purchased from Invitrogen (Cergy Pontoise,
France). Blasticidin was from Funakoshi Co. (Japan); AMV reverse
transcriptase was from QBiogene (Illkirch, France). Effectene
transfection reagent was from Qiagen (Courtaboeuf, France).
Luminol, ionomycin, horseradish peroxidase, thapsigargin, diphe-
nyleneiodonium chloride (DPI), rotenone, Nv-nitro-L-arginine
methyl ester hydrochloride (L-NAME), tiron, xanthine, benzoqui-
none (BQ), hydroquinone (HQ), 2,5-dimethyl-1,4-benzoquinone
(tMetBQ), duroquinone, 2,5-di-tert-butyl-1,4-benzo-hydroquinone
(tBuBHQ), 2,5-di-tert-butyl-1,4-benzoquinone (tBuBQ), 2-(12-
hydroxydodeca-5,10-diynil)-3,5,6-trimethyl-p-benzoquinone (AA-
861), 3,30-methylene-bis-4-hydroxycoumarin (Dicoumarol), cyclo-
heximide (CHX) compounds were purchased from Sigma (Saint
Quentin Fallavier, France). b-Mercaptoethanol was purchased fromCarlo Erba (Val de Reuil, France). LightCycler FastStart DNA Master
plus SYBR Green I kit, protease inhibitors cocktail tablet, tosyl-
lysine-chloromethyl ketone (TLCK), NADPH, NADH, xanthine
oxidase, and lactate dehydrogenase (LDH) optimized kits were
purchased from Roche (Meylan, France). Leupeptin, pepstatin, and
ECL reagents were from GE Healthcare (Orsay, France). UNI-ZAP
human kidney lambda cDNA library was purchased from Stratagene
(La Jolla, CA). Housekeeping gene GAPDH was purchased from BD
Bioscience (Pont de Claix, France). SuperScriptIII ﬁrst-strand
synthesis was obtained from Life Technologies (Saint Aubin, France).
2.2. Cell culture
Nox4 T-RExTM cells were a generous gift from K.H. Krause
(Department of Pathology and Immunology, Gene`ve, Suisse) and
were generated from HEK293 cell (Invitrogen). The HEK293E cell
line was purchased from Invitrogen (Cergy Pontoise, France). PLB-
985 human myeloid cell lines (wild type PLB-985 WT) or knock out
for Nox2 (PLB-985 KO-Nox2) were a generous gift from M. Dinauer
(Department of Pediatrics, St. Louis, USA). PLB-985 cells were
cultured at 37 8C under a 5% CO2 atmosphere in RPMI 1640
medium containing 2 mM L-glutamine supplemented with 10%
fetal bovine serum and with 1% penicillin/streptomycin. The
HEK293E cell line was maintained in DMEM supplemented with
10% (v/v) fetal bovine serum (FBS), 100 units/mL penicillin,
100 mg/mL streptomycin, 2 mM L-glutamine at 37 8C in a 5% CO2
humidiﬁed atmosphere. Five mg/mL Blasticidin was added to the
culture medium of cells transfected with the mammalian
expression plasmid pEF6V5/HisB.
The T-RExTM system was used for Tetracycline-inducible
expression of the genes of interest. T-RExTM cells stably expressing
Tet repressor were selected by 5 mg/mL Blasticidin and maintained
in DMEM supplemented with 10% (v/v) FBS, 2 mM L-glutamine at
37 8C in a 5% CO2 humidiﬁed atmosphere. T-REx
TM Nox4 cells as
compared to T-RExTMWT are able to induce Nox4 expression. Both
cells were selected with 5 mg/mL blasticidin and 400 mg/mL G418.
Nox4 expression was induced by the addition of 1 mg/mL
tetracycline in the culture medium. Experiments were performed
after the incubation at set times.
2.3. Isolation of human neutrophils
As previously reported [35], human neutrophils were isolated
from citrated venous blood of healthy volunteers. Blood samples
were diluted twice in PBS (137 mM NaCl, 2.7 mM KCl, 1.5 mM
KH2PO4, 8 mM Na2HPO4 pH 7.3) containing 1% (w/v) tri-sodium
citrate, using a 33% (v/v) Hypaque–Ficoll gradient. After 20 min of
centrifugation at 800  g at 20 8C, the pellet was submitted to a
hypotonic lysis for 5–15 min in ice. After 5 min of centrifugation at
350  g at 4 8C, the neutrophil pellet was collected and washed
once in PBS. Neutrophils were suspended in PBS containing 0.2%
(w/v) BSA and 0.5 mM CaCl2 at a concentration of 10
7 cells/mL and
used for superoxide measurement by chemiluminescence and
protein extraction.
2.4. Generation of plasmid constructs for Nox4 and NQO1 isoforms
expression
Two Nox4 cDNAs were characterized by PCR using UNI-ZAP
human kidney lambda cDNA library (Stratagene) as template.
Nox4A corresponds to the full length Nox4 usually described
(GenbankTM accession number: AF254621), and Nox4B is the 14
spliced exon isoform (GenbankTM accession number: AY288918).
Two NQO1 cDNAs were characterized by RT-PCR from mRNA
extracts of Nox4 T-RExTM cells, NQO1A (no. access NP_000894.1)
and NQO1C (no. access NP_001020605.1). Nox4A, Nox4B, NQO1A,
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expression as described [18].
2.5. Stable transfection of mammalian expression plasmids
HEK293E cells were trypsinized and counted; 4  105 HEK293E
cells were seeded in 6-well plates and allowed to grow for 24 h to
reach a 60% conﬂuence in 2 mL of culture medium. Cells were
transfected with 0.4 mg of vectors containing Nox4A or Nox4B
according to the manufacturing protocol (Effectene transfection
reagent, Qiagen). After 24 h of culture, stable transfected cells were
selected by 5 mg/mL blasticidin for 3 weeks before analysis.
2.6. Real time RT-PCR
Total RNA was extracted using a TRIzol1 reagent kit or RNeasy
Mini Kit (Qiagen) according to the manufacturer’s instructions.
Total RNA was treated with RNase-free DNase I (Qiagen). One or
5 mg of RNA were converted to cDNA by reverse transcription with
20 U of AMV reverse transcriptase or SuperScriptIII ﬁrst-strand
synthesis (Life Technologies). Real time PCRs were performed with
the LightCycler FastStart DNA Master plus SYBR Green I kit (Roche)
or QuantiTect SYBR Green RT-PCR kit (Qiagen) as described [18].
Real time RT-PCR was conducted using the LightCycler1 Carousel-
Based System (Roche) or a Stratagene Mx3005P (Stratagene).
Brieﬂy, the expression levels of human Nox4, NQO1 and
housekeeping GAPDH, RPL27 and RPL32 mRNAs were determined
using speciﬁc primers chosen to include intron spanning (Table 1).
PCRs were carried out for each sample in triplicate. Gene
expression was quantiﬁed using the comparative threshold cycle
(Ct) method. The amount of target gene, normalized to three
endogenous reference genes (RPL27, RPL32 and GAPDH) was
expressed relative to the control cells, as indicated in Figures. The
speciﬁcity of the products was conﬁrmed for each fragment by a
melting curve analysis and gel electrophoresis.
2.7. Protein extraction
Two methods were used. First, HEK293E cells were harvested
and lysed on ice in 1% (p/v) Triton X-100 buffer (20 mM Tris–HCl,Table 1
Primers used in this study for RT-PCR experiments. tot, total and exo, exogenous.
Name Primers (50. . .30) 
Real time RT-PCR
Nox4 Forward CTGAATGCAGCAAGATACCGAGAT 
Nox4 Reverse CTGGCTTATTGCTCCGGA 
NQO1 Forward a GAAGAGCACTGATCGTACTGGC 
NQO1 Reverse a GGATACTGAAAGTTCGCAGGG 
NQO1 Forward b GCAAGTCCATCCCAACTGACA 
NQO1 Reverse b CTAGAAGGCACAGTCGAGGC 
RPL27 Forward TGATGGCACCTCAGATCGC 
RPL27 Reverse AGAGTACCTTGTGGGCATTAGG 
RPL32 Forward TTAAGCGTAACTGGCGGAAAC 
RPL32 Reverse GAGCGATCTCGGCACAGTAA 
GAPDH Forward a CATGAGAAGTATGACAACAGCCT 
GAPDH Reverse a AGTCCTTCCACGATACCAAAGT 
GAPDH Forward b GTGGTGGACCTGACCTGC 
GAPDH Reverse b CCCTGTTGCTGTAGCCAAATTCG 
Semi-quantitative RT-PCR
GAPDH Forward BD Bioscience 
GAPDH Reverse BD Bioscience 
Actin Forward Clontech 
Actin Reverse Clontech 
NQO1 Forward GTTGGTACCATGGTCGGCAGAAGAGC 
NQO1 Reverse GTTACTAGTTCATTTTCTAGCTTTGATCTGG 
5-LO Forward CAAATGCCACAAGGATTTACCCCG 
5-LO Reverse CGTATTTTGCATCCGAAGGGAGGA 150 mM NaCl, 1 mM EDTA, pH 7.6), containing a protease inhibitor
cocktail containing 2 mM leupeptin, 2 mM pepstatin, and 10 mM
TLCK l, for 20 min at 4 8C. The lysate was then centrifuged at
10,000  g for 10 min at 4 8C and supernatant was used for
Western blotting experiments. Second, human neutrophils were
suspended at a concentration of 5  108 cells/mL in PBS containing
the protease inhibitor cocktail. The cells were sonicated for
3  10 s at 4 8C and 40 W using a Branson soniﬁer. The homogenate
was centrifuged at 1000  g for 15 min at 4 8C to remove unbroken
cells and nuclei. The post-nuclear supernatant was centrifuged at
200,000  g for 1 h at 4 8C. The pellet consisting of crude
membranes was suspended in the same buffer.
2.8. SDS-PAGE and Western blot
The Triton X-100 soluble extract, membrane or cytosol fractions
were loaded on a 7% or 10% SDS-PAGE and electro-transferred to
nitrocellulose, as previously described. Immunodetection was
performed using primary polyclonal antibodies against 5-lipox-
ygenase (dilution 1:2000) following by a secondary antibody
combined with horseradish peroxidase. The bound peroxidase
activity was measured using ECL reagents.
2.9. Determination of ROS production by chemiluminescence
ROS production was measured as previously described [18].
Cells were washed twice with PBS, detached with trypsin, and
collected by centrifugation (250 g, 5 min at 20 8C). The cell
viability was superior to 90%, as determined by the trypan blue
exclusion method. For measurement of Nox4 activity that is
constitutive, 5  105 living cells per well (96-well plate) were
resuspended in 250 ml of PBS containing 20 mM luminol and
10 U/mL horseradish peroxidase. The phagocyte oxidase (Nox2)
activity was initiated by 0.13 mM PMA or by 0.15 mM fMLP in
medium containing 0.9 mM CaCl2, 0.5 mM MgCl2, and 20 mM
glucose. Relative luminescence unit (RLU) counts were recorded
every minute for a total of 60 min using a Luminoscan1
luminometer (Labsystems, Helsinki, Finland). In some experi-
ments, chemical compounds (quinones) were added just before
luminescence measurement (Nox4) or before the addition ofGene TM
Nox4 66 8C
Nox4 66 8C
NQO1 tot 60 8C
NQO1 tot 60 8C
NQO1 exo 60 8C
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assay, ROS production was measured as previously in a medium
containing luminol and horse radish peroxidase plus 1 mM
Xanthine and 0.75 mUI Xanthine oxidase in the presence or not of
quinones.
2.10. Intracellular free Ca2+ measurement
Intracellular free Ca2+ levels were measured by ﬂow
cytometry (FACSCalibur, Becton Dickinson cytometer) using
Fluo-3/AM. The ﬂuorescence intensity of Fluo-3/AM dye was
detected in the gated cell population at 526 nm (FL1 channel),
which is proportional to the intracellular free calcium level. Cells
were harvested and then counted. 107 cells/mL, suspended in
Tyrode’s «free» buffer (10 mM HEPES, 145 mM NaCl, 2.5 mM KCl,
10 mM glucose, 1.2 mM MgCl2, pH 7.3) were incubated in a light
free environment with 10 mM of Fluo-3/AM for 30 min at 37 8C
before analysis. After washing cells with the Tyrode’s ‘‘free’’
buffer containing 1.5 mM CaCl2 or 1 mM EGTA, basal ﬂuores-
cence was measured at 526 nm for 1 min. Chemical compounds
were added to the tubes containing 5  106 cells per 500 ml, and
measurement was continued for 5 more minutes. The data
analysis was performed as follow: gates (5 s) were created along
the time axis of the dot plots windows at deﬁned time points, and
the mean ﬂuorescence intensity was statistically analyzed for
every gate (WinMDI 2.8 software).
2.11. Lactate dehydrogenase (LDH) activity measurement
The activity of LDH was measured in the incubation medium
as an index of plasma membrane integrity. Cells were washed
twice with PBS, detached with trypsin, collected by centrifuga-
tion (250 g, 5 min at 20 8C), and counted. In a 96-well plate,
5  105 cells per well were resuspended in 250 ml of PBS.
Cells were incubated with quinone compounds at different
concentrations for 60 min. At the end of the treatment period,
supernatants were collected and assessed for LDH activity on a
Hitachi/MODULAR automated analyzer using the Roche opti-
mized kit. The cell viability was expressed as the percentage of
LDH released into the incubation medium versus total cell
activity measured after cell lysis with 1% (v/v) Triton-X 100.
2.12. Statistical analysis
Data were expressed as the mean  SD. Statistical analysis was
performed using Mann and Whitney or Kruskal and Wallis tests. The
results are reported when signiﬁcantly different (p < 0.05) from
control.Fig. 1. Characterization of Nox4 expression and constitutive activity in HEK293E transfect
non-transfected WT-, Nox4A-, or Nox4B-HEK293E transfected cells. (B) Measurement of c
chemiluminescence on 5  105 intact WT-, Nox4A-, or Nox4B-HEK293E transfected c
overexpressing Nox4A was conﬁrmed by using several inhibitors: DPI (10 mM), rotenone 
of RLU measurements for 90 min. Values represent the mean  SD of triplicate determina
(A and B), or cells without inhibitors (C).3. Results
3.1. Overexpression of Nox4 in HEK293E cell line and constitutive
NADPH oxidase activity
Nox4 was identiﬁed for the ﬁrst time in tubular cells of adult
kidney and its oxidase activity was shown to be constitutive [13].
We, therefore, performed the functional characterization of Nox4
in HEK293E (human embryonic kidney) cell line which expresses
Nox4 mRNA but not Nox1 and Nox2, (unpublished data). The
oxidase activity of these cells was very low and was not sensitive to
PMA (unpublished data). We stably overexpressed two isoforms of
Nox4, Nox4A the active isoform (GenbankTM accession number:
AF254621), and a splicing variant Nox4B (GenbankTM accession
number: AY288918) that is unable to produce ROS due to the
absence of one NADPH binding sites [36]. The results showed a
signiﬁcant increase of mRNA expression encoding both Nox4
isoforms compared to WT cells (Fig. 1A). While the overexpression
of Nox4B failed to produce ROS, Nox4A demonstrated a
spontaneous ROS generation compared to WT-HEK293E cells
(Fig. 1B) and that corresponded to a NADPH oxidase activity since it
was solely inhibited by DPI (inhibitor of ﬂavoproteins) and Tiron
(superoxide scavenger) but not by rotenone (mitochondrial
respiratory chain inhibitor) and L-NAME (competitive inhibitor
of NO synthase) (Fig. 1C).
3.2. Stimulation of Nox4 activity by two quinone derivatives
Next, we evaluated the effect of two quinone compounds, AA-
861 and tBuBHQ on Nox4 constitutive activity. Incubation of
Nox4A-HEK293E cells with AA-861 or tBuBHQ led to an increase of
ROS production (Fig. 2A). The stimulated activity reached its
optimum level at 10 min or 20 min after AA-861 or tBuBHQ
incubation respectively. The incubation with WT-HEK293E cells
did not lead to a high level of ROS production. In fact, only small
increase of ROS was observed reﬂecting the stimulation of the
endogenous Nox4 by those two quinones (Fig. 2A, inset). The
speciﬁcity of a NADPH oxidase activity was conﬁrmed by using DPI
which had an inhibitory effect whereas rotenone and L-NAME did
not (Fig. 2A).
To conﬁrm that the observed effect of AA-861 and tBuBHQ was
speciﬁcally related to Nox4 proteins, we used two other
characterized cell lines that over-expressed Nox4: human chon-
drocyte C-20/A4 [18] and Nox4 T-RExTM in which Nox4 expression
could be temporally induced by the addition of tetracycline [27].
Consistently, the constitutive ROS production in Nox4 C-20/A4
cells or in 4 h-induced Nox4 T-REx cells was enhanced after the
addition of AA-861 or tBuBHQ (Fig. 2B and C). It is noticeable thated cells. (A) Real-time RT-PCR analysis of Nox4 mRNA. Total RNA was extracted from
onstitutive ROS production by HEK293E cells. The ROS production was measured by
ells. (C) The speciﬁcity of constitutive NADPH oxidase activity of HEK293E cells
(Rot, 1 mM), L-NAME (L-N, 100 mM), tiron (0.5 mM). Results are expressed as the sum
tions of at least 3 independent experiments, *p < 0.05 versus cells without transfection
Fig. 2. AA-861 and tBuBHQ stimulate ROS production by Nox4A-HEK293E cells and two other cellular models. (A) Stimulation of ROS generation by the endogenous Nox4
(inset) in WT-HEK293E cells or Nox4A-HEK293E cells with 50 mM tBuBHQ or 10 mM AA-861. The ROS production was measured by chemiluminescence on 5  105 intact
cells and results are expressed as the sum of RLU measurements for 90 min. The speciﬁcity of NADPH oxidase activity stimulation by tBuBHQ or AA-861 was demonstrated by
using several inhibitors: DPI (10 mM); rotenone (Rot, 1 mM) and L-NAME (L-N, 100 mM). Values represent the mean  SD of triplicate determinations of at least 3 independent
experiments, *p < 0.05 versus cells without activators. ROS production by human chondrocyte cell line C-20/A4 (B) or Nox4 T-RExTM cells (C) [27] induced 4 h or not with 1 mg/mL
tetracycline (tet-induced) was measured after the addition or not of 10 mM AA-861 or 50 mM tBuBHQ. Results are expressed as the sum of RLU measurements for 90 min for each
condition. Values represent the mean  SD of triplicate determinations and are representative of at least 3 independent experiments, *p < 0.05 versus cells without activators. (D)
Real-time RT-PCR analysis of Nox4 mRNA time course expression. Total RNA was extracted from Nox4 T-RExTM exposed to tetracycline from 0 to 8 h. (E) In order to stop de novo
protein translation, tet-induced Nox4 T-RExTM cells were treated with cycloheximide (CHX). After 2 h of tetracycline induction, tet-induced Nox4 T-RExTM cells were incubated with
CHX (100 mg/mL) or not for 2 more hours and then ROS measurements by chemiluminescence of 5  105 intact cells was performed. Results are expressed as the sum of RLU
measurements for 90 min and are shown as percentage of ROS produced by Nox4 T-RExTM cells after 4 h of tet-induction without CHX treatment. Values represent the mean  SD of
triplicate determinations of at least 3 independent experiments, *p < 0.05 versus cells without AA-861 in same conditions.
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express Nox4, was not affected by AA-861 or by tBuBHQ indicating
that those two quinones do not produce ROS spontaneously in the
presence of cells (Fig. 2C). Considering the short time course of AA-
861 and tBuBHQ stimulation, it is unlikely that the augmentation
of Nox4 activity observed was correlated to an increase of its
protein expression. However, to rule out this eventuality, we
inhibited Nox4 protein synthesis by using cycloheximide (CHX), an
inhibitor of protein translation. The time course of the Nox4 mRNA
expression induced by tetracycline indicated that the maximum
level was reached at 4 h and then remained constant until 8 h
(Fig. 2D). After 2 h of Nox4 induction by tetracycline, time point
when the Nox4 mRNA synthesis is still increasing, CHX was added
in the medium of Nox4 T-RExTM cell line and oxidase activity was
measured after two additional hours of incubation. As expected,
CHX-treated cells exhibited a lower constitutive oxidase activity
(66%), indicating a lower amount of induced Nox4 proteins,
compared to non-CHX-treated cells (Fig. 2E, white bars). Although
an increase of Nox4 protein was abolished under CHX treatment,
Nox4 activity was still stimulated by AA-861 incubation (Fig. 2E,
black bars compared to white). These results support our aboveconsideration that AA-861 speciﬁcally increases Nox4 activity
independently of its protein level.
3.3. Molecular mechanism and signiﬁcance of Nox4 activity
stimulation by quinone compounds AA-861 and tBuBHQ: 5-
lipoxygenase and calcium ﬂux are not involved in the activation of
Nox4
Since AA-861 was described as a 5-lipoxygenase (5-LO)
inhibitor, we investigated whether 5-LO could be implicated in
the stimulation of Nox4 activity. 5-LO was originally reported to be
expressed in leucocytes and some epithelial cells [37], but no data
concerning 5-LO expression in the HEK293E cell line are available.
We found that neither 5-LO mRNA nor 5-LO protein was expressed
in HEK293E cells (Fig. 3A and B), which excludes the involvement
of 5-LO in Nox4 activation by AA-861. Furthermore, MK-886,
another 5-LO inhibitor did not modulate Nox4 activity (unpub-
lished observations).
The relationship between calcium ion ﬂux and Nox4 activity
has not been clearly described. Pedruzzi et al. [16] reported that
Nox4 activity located in the endoplasmic reticulum was
Fig. 3. AA-861 or tBuBHQ NADPH oxidase activity stimulation is independent of 5-lipoxygenase and of calcium ﬂux. (A) 5-lipoxygenase mRNA expression in HEK293E cells.
Total RNA was extracted from HEK293E and B lymphocytes (BL), a semi-quantitative RT-PCR was performed using speciﬁc primers for 5-lipoxygenase (5-LO). The
housekeeping actin gene (Act) was used as a positive control. (B) 5-lipoxygenase protein expression in HEK293E cells. 150 mg of total proteins from HEK293E WT, and 75 mg
of cytosolic (Cyto) protein fraction (positive control) from neutrophils (PMN) were loaded on a 7% SDS-PAGE gel. 5-lipoxygenase proteins were characterized with a speciﬁc
monoclonal antibody against 5-LO. (C) and (D) Calcium ﬂux measurement was assessed by a ﬂuorescent probe in Nox4A-HEK293E cells. Intact cells were incubated with
10 mM Fluo3/AM with or without 20 mM BAPTA, during 30 min at 37 8C, washed and resuspended at 106 cells/mL. Calcium ﬂux visualization was performed by ﬂow
cytometry. The arrow indicates the time of the addition of ionomycin (Iono, 10 mM), AA-861 (10 mM), tBuBHQ (50 mM), or thapsigargin (Thaps, 10 mM) in presence of 1 mM
EGTA (C); or that of tBuBQ (50–200 mM) and tBuBHQ (50–200 mM) (D). Results are expressed as the mean of the ﬂuorescence intensity (FL1 change) measured every 5 s (E).
5  105 intact HEK293E cells overexpressing Nox4A were incubated or not with ionomycin (Iono, 10 mM), thapsigargin (Thaps, 10 mM), AA-861 (10 mM), or tBuBHQ (50 mM)
in presence of 1 mM EGTA and then the ROS production was measured by chemiluminescence. Results are expressed as the sum of RLU measurements for 90 min.
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terol. However in a previous study, we showed that ionomycin
(calcium ionophore) had no effect on the Nox4 activity in
chondrocytes C-20/A4 cells over-expressing Nox4A [18]. Since
tBuBHQ was described as a SERCA pump inhibitor, it is necessary
to evaluate the potential contribution of the Ca2+ ﬂux on Nox4
stimulation. To this purpose, we measured the calcium ﬂux in
Nox4-HEK293E cells by FACs using a ﬂuorescent Fluo-3/AM
probe and compared the calcium changes to Nox4 activation. As
illustrated in the ﬁgure 3 (Fig. 3C and D), an increase of cytosolic
calcium from intracellular stores was observed in the presence
of extracellular EGTA after adding ionomycin, thapsigargin or
tBuBHQ whereas the addition of AA-861 or tBuBQ, two
compounds that stimulate Nox4 activity were unable to modifyCa2+ level. Furthermore, thapsigargin or ionomycin could not
modulate the constitutive activity of Nox4 in Nox4-HEK293E
cells (Fig. 3E). Same experiments were performed in the
presence of 1.5 mM CaCl2 in the extracellular medium without
EGTA and led to the same results (unpublished observations).
These data strongly suggest that there is no correlation between
Ca2+ ﬂux and Nox4 activity.
3.4. Quinone structure may be responsible for the modulation of Nox4
activity
AA-861 and tBuBHQ share the same quinone moiety. To
evaluate whether quinone structure was responsible for Nox4
activation, the ROS production by Nox4-HEK293E cells was
Table 2
Quinone effect on Nox4 ROS production of Nox4A-HEK293 cells. Data were
expressed as the mean  SD.
Effect Structure [C] mM ROS production
None
PBS 9.01  0.8
Activators
AA-861 1 24.26  0.91*
5 34.40  1.16*
10 45.70  0.77*
50 37.20  2.14*
tBuBHQ 1 14.20  0.76
10 36.01  0.68*
50 61.74  0.78*
100 38.90  1.82*
tBuBQ 1 13.58  0.42
10 32.70  0.22*
50 36.50  0.63*
100 34.99  1.22*
Duroquinone 1 35.69  1.65*
10 30.21  1.70*
50 29.30  1.80*
Inhibitors
Benzoquinone 0.01 7.88  0.36
0.5 8.09  0.37
1 7.69  0.51
3 3.63  0.15*
30 1.01  0.11*
Hydroquinone 0.01 7.65  0.50
0.5 8.09  0.37
1 8.70  0.52
3 4.18  0.34*
30 0.12  0.07*
tMetBQ 1 10.09  1.68
10 12.70  0.43
50 12.87  0.82
100 1.32  0.20*
200 0.38  0.01*
Plumbagine 0.01 7.40  0.67
0.5 6.64  0.27
1 4.00  0.22*
5 1.93  0.29*
10 1.34  0.09*
* p < 0.01 versus PBS treated cells.
Table 3
Cytotoxicity of quinones and ROS production in the presence of phosphatidylcho-
line.
Structure [C] mM Toxicity %LDHa ROS productionb
PBS PC
– – 10.80  0.29 1.9  0.1 2.7  0.2
Benzoquinone 1 11.37  0.53 ND ND
30 10.72  0.53 2.0  0.1 2.3  0.2
Hydroquinone 1 10.73  0.53 ND ND
30 10.99  0.80 2.1  0.1 2.3  0.1
tMetBQ 50 12.79  0.97 2.3  0.3 2.4  0.1
200 12.66  1.00 ND ND
tBuBQ 50 12.44  0.42 2.3  0.1 2.2  0.2
tBuBHQ 50 11.93  1.41 4.4  0.9 6.8  0.4
Duroquinone 50 11.03  1.13 2.3  0.1 2.8  0.2
AA-861 10 12.00  0.84 2.3  0.1 2.4  0.3
a Cytotoxicity evaluation of quinone compounds on HEK293E cell line. 5  105
intact HEK293E were incubated with chemical compounds and lactate dehydroge-
nase (LDH) activity was assessed 60 min later in the culture medium. Values
represent the mean percentage of LDH activity compared to total LDH enzymatic
activity (cells lyzed by a treatment with 1% triton X-100).
b Luminol chemiluminescence measurements of quinone alone (PBS column) or
with only 25 mg of phosphatidylcholine (PC column) demonstrated no spontaneous
ROS production. Values represent the mean percentage of NADPH oxidase activity
compared to constitutive ROS production by Nox4A-HEK293E alone.
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differ with respect to their reduced or oxidized state and
substitution levels. The results shown in Table 2 illustrate two
opposite effects. Duroquinone as well as tBuBHQ, tBuBQ (the
oxidative form of tBuBHQ), and AA-861, stimulated Nox4 activity
at a starting concentration of 1 mM, whereas BQ (30 mM), HQ
(30 mM) and tMetBQ (100 mM) inhibited this activity in a dose
dependent manner. We also conﬁrmed the inhibitory effect of the
naphthoquinone, plumbagin, on Nox4 activity as reported [38,39].
To exclude a non-speciﬁc spontaneous ROS production by
quinone compounds in contact with membrane phospholipids as
described for tBuBHQ [40], we measured the ROS synthesis in the
presence of 25 mg phosphatidylcholine. The results illustrated in
Table 3 show that there was no ROS enhancement by quinones
after addition of phospholipids versus control, except for a slight
increase observed as expected with tBuBHQ, as previously
reported [40]. Furthermore, quinone concentrations used in this
study were not cytotoxic as examined by the LDH activity (Table 3).
3.5. Effect of quinones on Nox2
We next evaluated whether those quinones could affect Nox2
oxidase activity in isolated human neutrophils which express onlyNox2, the redox core of phagocyte NADPH oxidase. Compared to
the well known activator PMA, no NADPH oxidase activation was
observed when neutrophils were incubated with AA-861, tBuBQ,
or duroquinone (Fig. 4A) as opposed to what was previously
observed in Nox4 T-RExTM cells (Table 2). However, slight oxidase
activation was observed upon the addition of tBuBHQ, probably
due to its effect on the calcium ﬂux since thapsigargin, another
SERCA pump inhibitor, or ionomycin gave similar results (unpub-
lished data). On the contrary, the quinones BQ, HQ, tMetBQ, and
plumbagin also inhibited the PMA stimulated neutrophil oxidase
activity (Fig. 4B). By using an in vitro xanthine/xanthine oxidase
superoxide production system, we observed that the ROS
production was abolished in the presence of 30 mM BQ, 30 mM
HQ, and 100 mM tMetBQ while no effect on the xanthine/xanthine
oxidase ROS production was noticeable with 50 mM duroquinone,
50 mM tBuBHQ, 50 mM tBuBQ, or 10 mM AA-861 (unpublished
data). Using differentiated PLB-985 as another cellular model, we
obtained similar results than those observed with human PMN
(Fig. 4C). We, next, evaluated whether quinones could increase
Nox2 activity already activated by the physiological agonists (the
formylated peptide fMLP) in differentiated PLB-985 cells and found
that AA-861, tBuBQ, and duroquinone did not stimulate Nox2
activity (Fig. 4D).
These results suggest that BQ, HQ, and tMetBQ inhibit ROS
production through an antioxidant property. On the contrary,
duroquinone, tBuBHQ, tBuBQ, and AA-861 appear to stimulate
speciﬁcally NADPH oxidase activity of Nox4.
3.6. Putative quinone binding site (Q site) on Nox4
Quinones compounds bind to its target proteins through well
described ubiquinone binding sites [41]. Based on computational
prediction, a consensus sequence for a predictable quinone binding
site or Q site was suggested: ‘‘aliphatic-(X)3-H-(X)2-3-(Leu/Thr/
Ser)’’ [42]. The analysis of the Nox4 protein sequence showed a
similar putative motif in the ﬁfth transmembrane domain
(‘‘203LLTLHVS209’’) that is missing in Nox2 sequence (Fig. 5A).
Therefore, quinones could regulate Nox4 activity by binding
directly to the protein through this putative domain. To investigate
the relevance of this potential Q site in Nox4 protein, we mutated
Fig. 4. Effect of quinone derivatives on the activation of Nox2 oxidase activity. (A) The reactive oxygen species production was measured by chemiluminescence on 5  105
intact PMN cells in the presence of an increasing concentration (1 mM, 10 mM, or 50 mM) of AA-861, tBuBQ, tBuBHQ, or duroquinone. Results are expressed as the sum of RLU
measurements for 60 min and are shown as percentage of ROS produced by PMN stimulated by PMA (0.13 mM). Values represent the mean  SD of triplicate determinations of
at least 3 independent experiments, *p < 0.05 versus cells without PMA activation and quinones. (B) PMN (5  105 cells) were stimulated by PMA (0.13 mM) in the presence or not of
BQ (1 mM, 3 mM, and 30 mM), HQ (1 mM, 3 mM, and 30 mM), tMetBQ (10 mM, 50 mM, and 100 mM) or plumbagin (1 mM and 5 mM). Results are expressed as the sum of RLU
measurements for 90 min and are reported as a percentage of ROS produced by PMN stimulated by PMA (0.13 mM). Values represent the mean  SD of triplicate determinations of at
least 3 independent experiments, *p < 0.05 versus cells activated by PMA without quinones. (C) The reactive oxygen species production was measured by chemiluminescence on
5  105 intact differentiated PLB-985 cells in the presence of 30 mM BQ, 30 mM HQ, 50 MetBQ, 10 mM AA-861, 50 mM tBuBQ, 50 mM tBuBHQ, or 50 mM duroquinone. Results are
expressed as the sum of RLU measurements for 60 min and are shown as percentage of ROS produced by differentiated PLB-985 cells stimulated by fMLP (0.15 mM). Values represent
the mean  SD of triplicate determinations of at least 3 independent experiments, *p < 0.05 versus cells without fMLP activation and quinones. (D) Differentiated PLB-985
(5  105 cells) were stimulated by fMLP (0.15 mM) in the presence or not of 30 mM BQ, 30 mM HQ, 50 MetBQ, 10 mM AA-861, 50 mM tBuBQ, 50 mM tBuBHQ, or 50 mM duroquinone.
Results are expressed as the sum of RLU measurements for 60 min and are reported as a percentage of ROS produced by differentiated PLB-985 cells stimulated by fMLP (0.15 mM).
Values represent the mean  SD of triplicate determinations of at least 3 independent experiments, *p < 0.05 versus cells activated by fMLP without quinones.
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L203G and S209A (Fig. 5A). Our results showed that those
mutations did not modify the stimulatory effect of the quinone
tBuBHQ on Nox4 activity which remained similar to WT Nox4
(Fig. 5B). Since our data showed that quinones did not activate
Nox2 activity nor enhance its activity (Fig. 4), we therefore
exchanged the sequence 201Y. . .Y215 of Nox4, which contains
the putative Q binding of Nox4, with the homologous sequence of
Nox2 216F. . .G230. This Nox4/2 chimera protein remained still
stimulated by tBuBHQ (Fig. 5B). Those results suggest that this
putative Q site domain on Nox4 is not involved in the stimulation
of Nox4 activity by quinone compounds.
3.7. Redox regulation of Nox4 activity
A recent study [43] showed that structural modiﬁcations of the
E-loop, by deletion or exchange of cysteine, had an impact on the
production rate and nature of ROS generated. The authors
hypothesized that extracellular cysteines C226 and C270 might
form a disulﬁde bridge that modulates Nox4 ROS production.
Quinones compounds are highly reducing molecules capable of
breaking disulﬁde bridges and, therefore, could modulate Nox4
activity through a redox regulation. To test this hypothesis, we
measured the effect of known reducing agents on Nox4 activity
and found that in tet-induced Nox4 T-RExTM cells, the addition of
80 mM NADPH, NADH, or b-mercaptoethanol increased signiﬁ-
cantly the ROS production compared to non-induced and
untreated Nox4 T-RExTM cells (Fig. 5C). These results suggest that
reducing agents stimulate Nox4 activity and point out a possiblemechanism by which quinones might regulate Nox4 activity by
reducing the E-loop disulﬁde bridge.
3.8. Involvement of NQO1 on Nox4 activation by quinone
Quinone compounds are metabolized through different path-
ways and one of them involves the NAD(P)H oxidoreductase 1
(NQO1). By RT-PCR and sequencing, we revealed that Nox4 T-
RExTM cells expressed two types of mRNA encoding for NQO1:N-
QO1A, the active form and NQO1C, the inactive form, which lacks 2
essential amino acid residues (Tyrosine-126 and -128) necessary
for its quinone binding capacity [4]. To investigate the potential
role of NQO1 in the stimulation of Nox4 activity by quinone
compounds, we used dicoumarol to inhibit NQO1. Pre-incubation
of the tetracycline induced Nox4 T-RExTM cells with 100 mM
dicoumarol inhibited Nox4 constitutive activity as well as its
stimulation by tBuBHQ (Fig. 6A). To further investigate the role of
NQO1, we stably overexpressed NQO1A and NQO1C in Nox4-
HEK293 and conﬁrmed the presence of the exogenous NQO1A and
NQO1C mRNA in the corresponding transfected cells compared
with the empty vector control transfected cells (Fig. 6B). Further-
more, by real time RT-PCR we showed the mRNA level of NQO1A
and NQO1C increased 2 and 8 fold, respectively, compared to the
control Nox4-HEK293 cells (Fig. 6B). We then investigated the
consequences of these overexpressions on Nox4 activity. Results
showed that overexpression of NQO1A enhanced twice the
stimulatory effect of tBuBHQ on Nox4 activity compared to the
control empty vector cells. This is consistent with the increase level
of NQO1A mRNA observed previously (Fig. 6B). On the contrary,
Fig. 5. Putative Q site and redox regulation of Nox4 activity. (A) Schematic
representation of the alignment of partial sequences of Nox4, Nox2 and Nox4
mutants (Nox4L203G/S209A and Nox4/2). Gray box represents the predicted 5th
transmembrane domain. Boxed amino acids on Nox4 sequence correspond to the
putative Q site and bold letters are key amino acids described for the Q site [42].
Underlined amino acids represent amino acids that have been exchanged from
Nox2 sequence to produce the chimera Nox4/2. (B) Measurement of ROS generation
by chemiluminescence on 5  105 intact transfected Nox4-, Nox4L203G/S209A- and
Nox4/2-HEK293 cells with or without 50 mM tBuBHQ. (C) Measurement of ROS
generation by chemiluminescence on 5  105 intact cells. ROS production by Nox4
T-RExTM cell induced 4 h or not with 1 mg/mL tetracycline (tet-induced) was
measured after the addition or not of NADPH, NADH, b-mercaptoethanol (b-ME)
(80 mM of each), or tBuBHQ (50 mM). Results are expressed as the sum of RLU
measurements for 90 min for each condition. Values represent the mean  SD of
triplicate determinations of at least 3 independent experiments, *p < 0.05 versus cells
without redox compounds.
Fig. 6. Effect of NQO1 on tBuBHQ activation of ROS production by Nox4. (A) Nox4 T-
RExTM cells were induced (or not) with 1 mg/mL tetracycline for 4 h. Dicoumarol
was added in the culture medium 2 h before ROS measurements.
Chemiluminescence assay was done on 106 intact cells per well, activated or not
by 50 mM tBuBHQ. Results are expressed as the sum of RLU measurements for
90 min. Values represent the mean  SD of triplicate determinations of at least 3
independent experiments, *p < 0.05 versus cells in same condition without
dicoumarol. (B) Real-time RT-PCR analysis of exogenous and total NQO1 mRNA in
Nox4A-, Nox4A/NQO1C- and Nox4A/NQO1A-HEK293 cells. Left panel, real time RT-PCR
showing the presence of exogenous NQO1 mRNA in Nox4A/NQO1C- and Nox4A/
NQO1A-HEK293 cells and not in Nox4A-HEK293 transfected with the control pEFb
empty plasmid. N.D., not detected. Right panel, real time RT-PCR showing the increase
of NQO1 mRNA level in Nox4A/NQO1C- and Nox4A/NQO1A-HEK293 cells compared to
Nox4A-HEK293 transfected with the control pEFb empty plasmid. (C) Nox4A-HEK293E
cells were transfected with the empty vector pEFb (Control) or containing NQO1A or
NQO1B. The reactive oxygen species production was measured by chemiluminescence
on 5  105 intact cells after the addition of 50 mM tBuBHQ or the same volume of
vehicle (DMSO). Results are expressed as the sum of RLU measurements for 90 min.
Values represent the mean  SD of triplicate determinations of at least 3 independent
experiments, *p < 0.005 versus cells transfected with the control empty vector in same
conditions.
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NQOA, it did not modify the stimulatory effect which is comparable
to that observed with the control empty plasmid (Fig. 6C).
Together, these data suggest the implication of NQO1 enzymes in
quinone-stimulated Nox4 activity.
4. Discussion
Our study focuses on the capacity of quinone compounds to
modulate the NADPH oxidase activity of Nox4. Quinones are
important toxic compounds present in air pollution and abundant
in all burnt organic material, including urban air particles, cigarette
smoke, and diesel exhaust particles (DEP) [44]. DEP were reported
to increase Nox4 ROS production after 1 h of incubation,
suggesting the implication of Nox4 in the quinone metabolism
[9]. Considering the structure/function relationship of the qui-
nones used in this study (Table 2), we observed a dual stimulation/
inhibition effect that depends on their substitution state: Nox4
activity was stimulated by AA-861, duroquinone, tBuBQ, and
tBuBHQ whereas other less substituted derivatives such as BQ, HQ,tMetBQ, and plumbagin, developed antioxidant properties
(Table 2). The speciﬁcity of AA-861, duroquinone, and tBuBQ for
Nox4 over Nox2, suggests either a direct effect of quinone
derivatives in the molecular dynamics of electron transfer
mediated by Nox4, or an indirect role on a quinone sensitive
functional partner of Nox4. In this work, we suggest a new aspect
of Nox4 oxidase activity regulation that takes place not only
at a transcriptional level as usually described [13,27,45] but also at
a post-translational level as described above with quinone
molecules.
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mechanism. Ubiquinone, for example, is a mobile electron carrier
of mitochondria and a highly hydrophobic molecule that diffuses
into the core of inner membrane where the electron transfer
proceeds through a Q cycle on either side of membrane [41,46].
A predictable quinone binding site has been suggested [42] and
we identiﬁed a similar domain in Nox4 protein sequence
‘‘203LLTLHVS209’’. However, the implication of such domain
was not conﬁrmed since the ability of quinones to stimulate
Nox4 activity was not abolished when appropriate residues of
this sequence were mutated (Fig. 5A and B).
Alternatively, Takac and his colleagues [43] have shown that
disulﬁde bridges formed by two cysteines C226 and C270 may be
involved in the maintenance of the extracellular E-loop integrity.
Indeed, the disruption of the bridge by mutagenesis modiﬁed
notably Nox4 ROS production [43]. Disulﬁde bridges with a
standard redox potential (E0) of 180 mV [47] could be reduced by
NADPH, NADH and b-mercaptoethanol that possess a lower E0
(324, 320, and 253 mV, respectively) [48]. Our results using
those reducing agents indicated that Nox4 activity could be
stimulated by extracellular redox modiﬁcations, possibly through
the reduction of its disulﬁde bridge. Interestingly, duroquinone,
which enhances Nox4 activity, has a low E0 (260 mV) [49] and
then could theoretically reduce disulﬁde bridge. Conversely,
compounds such as BQ, HQ and tMetBQ that do not stimulate
Nox4 exhibit a higher E0, 78 mV, 78 mV and 67 mV, respectively,
compared to that of the disulﬁde bridge. Thus, it is possible that
quinones exhibiting an E0 lower than that of disulﬁde bridge are
able to stimulate Nox4 activity.
NAD(P)H-quinone oxidoreductase-1 (NQO1) is a broadly
distributed FAD-dependent ﬂavoprotein that catalyses the reduc-
tion of a wide variety of quinone compounds. It reduces quinones,
by the transfer of 2 electrons, to the corresponding hydroquinones
which are the electron donor state capable to initiate reductive
reactions. We showed that NQO1 is expressed in uninduced or tet-
induced Nox4 T-RExTM cells; however, the stimulation of ROS
production by quinones occurs only when Nox4 expression was
induced. Moreover, the increase of Nox4 ROS production by
quinones was inhibited by a well known inhibitor of NQO1,
dicoumarol. Noticeably, dicoumarol also decreases Nox4 constitu-
tive activity in quinone-untreated Tet-induced Nox4 T-RExTM cells
(Fig. 6A), possibly by inhibiting the endogenous NQO1 enzymes.
More speciﬁcally, only the functional NQO1 enzyme, NQO1A,
enhanced the ROS production of Nox4 induced by quinone
compounds (Fig. 6C). Interestingly, NQO1 has been described to
partition between cytosol and plasma membrane [7] where Nox4
is also located in HEK293 cells [50]. These observations suggest a
potential link between NQO1 and Nox4. Such potential link could
be illustrated in pancreatic cancer. Pancreatic cancer is very
aggressive and unresponsive to treatments due to a resistance of
cells to apoptosis. Vaquero et al. [51] reported that ROS produced
by Nox4 are prosurvival and antiapoptotic for human pancreatic
adenocarcinoma cell lines, MIA PaCa-2 and PANC-1. In the MIA
PaCa-2 cell line, Lewis et al. [52] showed that inhibition of NQO1 by
dicoumarol suppresses the malignant phenotype of pancreatic
cancer cells and induces cell apoptosis.
Finally, our study described 4 quinones derivatives especially
AA-861 and tBuBHQ capable of enhancing Nox4 ROS production.
We showed that NQO1 may be involved in the stimulation of Nox4
ROS production induced by quinones. We further observed that
Nox4 activity is also stimulated in the presence of reducing agents
that may possibly act by reducing the disulﬁde bridge located in
the extracellular E-loop of Nox4. All together, we hypothesize that
in the presence of quinones, NQO1 may generate hydroquinone
forms, providing, therefore, potential reducing agents near Nox4
protein. Depending on the quinone redox potential, Nox4 E-loopdisulﬁde bridge could be disrupted consequently leading to the
increase of its oxidase activity. However, the direct implication of
the E-loop disulﬁde bridge needs further investigations. The
proposed model could provide new insight into the understanding
of molecular mechanism of the electron transfer through Nox4 and
also deﬁne new therapeutic targets in diseases in which quinones
and Nox4 are implicated.
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